Gene-gene interaction affects coronary artery disease risk;A interacção gene-gene afecta o risco de doença coronária

Revista Portuguesa de Cardiologia

Volumn 28, Issue 4, 2009, Pages 397-415

  Mendonça, Maria Isabel ^a   Dos Reis, R Palma ^b   Freitas, A Isabel ^b   Sousa, Ana Célia ^b   Pereira, Andreia ^b   Faria, Paula ^b   Gomes, Susana ^b   Silva, Bruno ^b   Santos, Nuno ^b   Serrão, Marco ^b   Ornelas, Ilídio ^b   Freitas, Sónia ^b   Freitas, C ^b   Araújo, José Jorge ^b   Brehm, António ^b   Cardoso, A Almada ^b  

^a HOSPITAL CENTRAL DO FUNCHAL   (Portugal)

^b NONE

Author keywords

Angiotensin converting enzyme; Coronary artery disease; Gene gene interaction; Genetic polymorphism; Risk factors

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE;

CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EPISTASIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 67649810164     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Domnita Crisan and Jeanne Carr. Angiotensin I Converting Enzyme. Genotype and Disease Association. Journal of Molecular Diagnostics 2002;2(3):105-115.
2. Yoram Yagil and Chana Yagil. The search for the genetic basis of hypertension. Curr Opin Nephrol Hypertens 2005;14:141-147. (Pubitemid 40396867)
3. Stratta P, Bermond F, Guarrera S, Canavese C, Carturan S, Dall'Omo A, Ciccone G, Bertola L, Mazzola G, Fasano E and Matullo G. Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant 2004;19:587-595.
4. Cheng S, Grow, MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936-949. (Pubitemid 29525202)
5. Tiret L, Bonnadeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type receptor gene polymorphism on risk of myocardial infarction. Lancet. 1994;344:910-914
6. Wang JG, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol. 2000;410:289-302. (Pubitemid 32008151)
7. Wang JG, Liu LZagato L et al. Blood Pressure in Relation to Three Candidate Genes in a Chinese Population. Journal Hypertens 2004; 22: 937-944. (Pubitemid 38680468)
8. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913. (Pubitemid 24295876)
9. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997;52:71-76. (Pubitemid 27344785)
10. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000;405:421-424 (Pubitemid 30367411)
11. Peng DQ, Zhao SP, Nie S, Li J. Gene-gene interaction of PPAR gamma and ApoE affects coronary heart disease risk. Int J Cardiol 2003;92(2-3):257-263 (Pubitemid 37509991)
12. Wilson P, Schaefer E, Larson M, Ordovas J. Apolipoprotein E Alleles and Risk of Coronary Disease. A Meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology 1996;16:1250-1255. (Pubitemid 26339712)
13. Strittmatter W J and Roses A D. Apolipoprotein E and Alzheimer Disease. Proc Natl Acad Sci USA 1995; 92(11): 4725-4727.
14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: Arch Intern Med 1997;157:2413-2446.
15. Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002;25:S5-S20. (Pubitemid 41185039)
16. World Health Organization. Obesity: Preventing and Managing the Global Epidemic 1998;Geneva-WHO.
17. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
18. Roland Asmar, Athanase Benetos, Jirar Topouchian, Pierre Laurent, Bruno Pannier, Anne Marie Brisac, Ralph Target, Bernard I. Levy. Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement. Validation and Clinical Application Studies. Hypertension 1995;26;485-490.
19. Hernández D, Lacalzada J, Salido E, Linares J, Barragán A, Lorenzo V. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphism. Kidney Int 2000;58:889-897. (Pubitemid 30620040)
20. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R. Linkage and Association Analysis of Angiotensin I-Converting Enzyme (ACE)-Gene Polymorphisms with ACE Concentration and Blood Pressure. Am J Hum Gene 2001; 68:1139-1148. (Pubitemid 32424413)
21. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met 235-Thr allele of the human angiotensinogen gene. Hum Mol Gen 1993;2:609-610. (Pubitemid 23140035)
22. Doria A, Ji L, Warram JH, Krolewski AS. Dde I polymorphism in the AGTR1 gene. Hum Mol Genet 1994; 3:1444.
23. Guo S.W., Thompson, E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-372.
24. Wigginton J.E., Cutler, D.J., Agbecasis, G.R. A note on exact tests of Hardy-Weinberg equilibrium. American Journal of Human Genetics 2005;76:887-893. (Pubitemid 40563110)
25. Pernod G, O Ormezzano, G Vanzetto. Gene-gene interactions in myocardial infarction. Lancet; 367:1729-1730.
26. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2: 91-99. (Pubitemid 33674000)
27. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-872. (Pubitemid 36331853)
28. Cristina Barlassina, Chiara Lanzani, Paolo Manunta, Giuseppe Bianchi. Genetics of essential hypertension: From Families to Genes. J Soc Nephrol 2000; 13: S155-S164.
29. Keith T. Human Genome-Wide Association Studies. Achieving Sufficient Power to Detect Disease Genes with the Quebec Founder Population. Genetic Engineering and Biotechnology News 2007; 27(2).
30. Van Geel PP, Pinto YM, Zwinderman AH, Henning RH, Van Boven AJ, Zukema JW, Van Gilst WH. Increased risk for ischaemic events is related to combined RAS polymorphism. Heart 2001;85 (4):458462. (Pubitemid 32973539)
31. Wang, Ji-Guang Liu Lifang, Zagato Laura, Xie Jinxiang, Fagard Robert, Jin Kugen, Wang Jinxiang, Li Yan, Bianchi Giuseppe, Staessen Jan A, Liu Lisheng. Blood pressure in relation to three candidate genes in a Chinese population. Journal of Hypertension 2004;22(5):937-944. (Pubitemid 38680468)
32. Rosendaal FR. Genetic studies in complex disease: the case pro association studies. J Thomb Haemost 2003;1:1679-1680
33. Cambien François. Genetics and Coronary Heart Disease. Future Cardiology, 2005 1(1):17-27.